Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CL<sup>pro</sup> Main Protease

Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CL<sup>pro</sup> Main Protease

The emergence of SARS-CoV-2, responsible for the global COVID-19 pandemic, requires the rapid development of novel antiviral drugs that would contribute to an effective treatment alongside vaccines. Drug repurposing and development of new molecules targeting numerous viral targets have already led t...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Barbara Herlah, Andrej Hoivik, Luka Jamšek, Katja Valjavec, Norio Yamamoto, Tyuji Hoshino, Krištof Kranjc, Andrej Perdih
Formaat: Artikel
Taal:English
Gepubliceerd in: MDPI AG 2022-04-01
Reeks:Pharmaceuticals
Onderwerpen:
bicyclo[2.2.2]octenes
molecular scaffolds
SARS-CoV-2
3CL<sup>pro</sup> main protease
COVID-19 antiviral drugs
Online toegang:https://www.mdpi.com/1424-8247/15/5/539

Internet

https://www.mdpi.com/1424-8247/15/5/539

Gelijkaardige items